The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Novartis; Pfizer/EMD Serono; Pierre Fabre
Potential markers of response and resistance to programmed cell death-1 blockade in first-line therapy of cisplatin-inilegible advanced urothelial cancer.
 
Alberto Carretero-Gonzalez
No Relationships to Disclose
 
Blanca Homet Moreno
No Relationships to Disclose
 
Marta Dueñas
No Relationships to Disclose
 
Mónica Martínez-Fernández
No Relationships to Disclose
 
Ray Manneh
No Relationships to Disclose
 
Alejandra Bernardini
No Relationships to Disclose
 
Carolina Rubio
No Relationships to Disclose
 
Felipe Villacampa
No Relationships to Disclose
 
Rosa M. García Martín
No Relationships to Disclose
 
Ramón García Escudero
No Relationships to Disclose
 
José L. Rodríguez Peralto
No Relationships to Disclose
 
Daniel Rueda
No Relationships to Disclose
 
Guillermo De Velasco
No Relationships to Disclose
 
Daniel E. Castellano
No Relationships to Disclose
 
Jesús M Paramio
No Relationships to Disclose